The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its dominance. While specific pharmaceutical companies may attempt to capitalize on relat